Establishment and characterization of a MALT lymphoma cell line carrying an API2‐MALT1 translocation
MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying t...
Saved in:
Published in: | Genes chromosomes & cancer Vol. 59; no. 9; pp. 517 - 524 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken, USA
John Wiley & Sons, Inc
01-09-2020
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient with histologic transformation of intestinal MALT lymphoma. The cells were suggested to carry API2‐MALT1 and MYC‐IGH translocations by chromosomal analysis, and these translocations were confirmed by polymerase chain reaction analysis. The expression of MYC was shown to be enhanced as a result of the MYC‐IGH translocation, and it is considered to have played a role in the histologic transformation of MALT lymphoma. Whole exome sequencing of BMA19 identified several nucleotide variations in genes reported to be mutated in previous studies of marginal zone lymphomas. The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal. Subtractive microarray analysis showed that one of the earliest events resulting from MALT1 inhibition is increased susceptibility to endoplasmic reticulum stress‐induced apoptosis. The BMA19 cell line is considered to conserve the biological properties of MALT lymphoma and is expected to be a valuable tool for research into the pathogenesis of MALT lymphoma with an API2‐MALT1 translocation. |
---|---|
AbstractList | MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient with histologic transformation of intestinal MALT lymphoma. The cells were suggested to carry API2‐MALT1 and MYC‐IGH translocations by chromosomal analysis, and these translocations were confirmed by polymerase chain reaction analysis. The expression of MYC was shown to be enhanced as a result of the MYC‐IGH translocation, and it is considered to have played a role in the histologic transformation of MALT lymphoma. Whole exome sequencing of BMA19 identified several nucleotide variations in genes reported to be mutated in previous studies of marginal zone lymphomas. The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal. Subtractive microarray analysis showed that one of the earliest events resulting from MALT1 inhibition is increased susceptibility to endoplasmic reticulum stress‐induced apoptosis. The BMA19 cell line is considered to conserve the biological properties of MALT lymphoma and is expected to be a valuable tool for research into the pathogenesis of MALT lymphoma with an API2‐MALT1 translocation. MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient with histologic transformation of intestinal MALT lymphoma. The cells were suggested to carry API2‐MALT1 and MYC‐IGH translocations by chromosomal analysis, and these translocations were confirmed by polymerase chain reaction analysis. The expression of MYC was shown to be enhanced as a result of the MYC‐IGH translocation, and it is considered to have played a role in the histologic transformation of MALT lymphoma. Whole exome sequencing of BMA19 identified several nucleotide variations in genes reported to be mutated in previous studies of marginal zone lymphomas. The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal. Subtractive microarray analysis showed that one of the earliest events resulting from MALT1 inhibition is increased susceptibility to endoplasmic reticulum stress‐induced apoptosis. The BMA19 cell line is considered to conserve the biological properties of MALT lymphoma and is expected to be a valuable tool for research into the pathogenesis of MALT lymphoma with an API2‐MALT1 translocation. |
Author | Otsuka, Yasuyuki Nakao, Kensuke Takaori‐Kondo, Akifumi Izumi, Kiyotaka Nishikori, Momoko Yuan, Hepei |
Author_xml | – sequence: 1 givenname: Kiyotaka surname: Izumi fullname: Izumi, Kiyotaka organization: Graduate School of Medicine, Kyoto University – sequence: 2 givenname: Momoko orcidid: 0000-0003-4171-2162 surname: Nishikori fullname: Nishikori, Momoko email: nishikor@kuhp.kyoto-u.ac.jp organization: Graduate School of Medicine, Kyoto University – sequence: 3 givenname: Hepei surname: Yuan fullname: Yuan, Hepei organization: Graduate School of Medicine, Kyoto University – sequence: 4 givenname: Yasuyuki surname: Otsuka fullname: Otsuka, Yasuyuki organization: Graduate School of Medicine, Kyoto University – sequence: 5 givenname: Kensuke surname: Nakao fullname: Nakao, Kensuke organization: Graduate School of Medicine, Kyoto University – sequence: 6 givenname: Akifumi surname: Takaori‐Kondo fullname: Takaori‐Kondo, Akifumi organization: Graduate School of Medicine, Kyoto University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32348592$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kLtOwzAUhi1URC8w8ALIEgsMbR3HzmWsqlIqFcHQ3TpxnDZVYhc7FSoTj8Az8iS4FxiQGI7OGb7z6dffRS1ttELoOiCDgBA6XEo5oDTh_Ax1ApImfUoj1trfjPubx23UdW5NCInClF-gdkhDlvCUdlAxcQ1kVelWtdINBp1juQILslG2fIemNBqbAgN-Gs0XuNrVm5WpAUtVVbgqtcISrN2Veulf8ehlRr8-PvdogBsL2lVGHhyX6LyAyqmr0-6hxcNkMX7sz5-ns_Fo3pcsSHlfKpoDT4uE5hnPU1BxJqM4plzGPnnBOeSMxSSNgDAVZYRllGd5BtIPyYuwh-6O2o01r1vlGlGXbp8VtDJbJ2iYRgkPWRB49PYPujZbq304QX0WxpKIx566P1LSGuesKsTGljXYnQiI2HcvfPfi0L1nb07GbVar_Jf8KdsDwyPwVlZq979JTMfjo_Ib4VSP7w |
CitedBy_id | crossref_primary_10_3389_fonc_2022_1060496 crossref_primary_10_3389_fonc_2023_1115943 crossref_primary_10_2147_JIR_S319023 |
Cites_doi | 10.1111/j.1349-7006.2002.tb01306.x 10.3324/haematol.2018.214957 10.1111/j.1349-7006.2003.tb01518.x 10.1038/nrc3748 10.1158/0008-5472.CAN-17-2485 10.1158/1078-0432.CCR-15-2296 10.1016/S0002-9440(10)64157-0 10.1016/S0002-9440(10)64988-7 10.1097/MOH.0000000000000051 10.1016/j.molimm.2020.01.006 10.1016/j.semcancer.2013.11.005 10.1182/blood.V88.3.985.bloodjournal883985 10.1046/j.1365-2141.2003.04035.x 10.1126/science.1198946 10.1038/onc.2014.186 10.1182/blood.V95.3.802.003k19_802_806 10.1016/S1074-7613(03)00029-3 10.1038/nm.3884 10.1016/S0002-9440(10)65012-2 10.1007/s12185-019-02810-y 10.1038/nprot.2008.211 10.1101/gad.871201 10.1182/blood-2002-11-3502 10.1084/jem.20120904 10.1074/jbc.271.10.5513 10.1016/S0002-9440(10)64948-6 10.1016/j.ccr.2012.11.003 10.1002/(SICI)1096-9896(199704)181:4<381::AID-PATH787>3.0.CO;2-I 10.1371/journal.pone.0083244 10.1038/nrc1409 10.1074/jbc.M009984200 10.1093/nar/gkq603 10.1093/nar/gkn923 |
ContentType | Journal Article |
Copyright | 2020 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2020 Wiley Periodicals, Inc. |
DBID | NPM AAYXX CITATION 7QP 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1002/gcc.22855 |
DatabaseName | PubMed CrossRef Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Calcium & Calcified Tissue Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Genetics Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-2264 |
EndPage | 524 |
ExternalDocumentID | 10_1002_gcc_22855 32348592 GCC22855 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Japan Society for the Promotion of Science funderid: 18K08324 – fundername: Japan Society for the Promotion of Science grantid: 18K08324 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GLUZI GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZGI ZZTAW ~IA ~WT NPM AAMNL AAYXX CITATION 7QP 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4195-ce2da59f82db5d9ae7bc67725c7639f55ad447096a04e6b04b25bdbacdba0df3 |
IEDL.DBID | 33P |
ISSN | 1045-2257 |
IngestDate | Fri Aug 16 05:59:20 EDT 2024 Mon Nov 18 21:24:12 EST 2024 Thu Nov 21 23:59:50 EST 2024 Sat Sep 28 08:27:49 EDT 2024 Sat Aug 24 01:06:30 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | MALT lymphoma microarray analysis API2-MALT1 cell line MALT1 inhibitor |
Language | English |
License | 2020 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4195-ce2da59f82db5d9ae7bc67725c7639f55ad447096a04e6b04b25bdbacdba0df3 |
Notes | Funding information Japan Society for the Promotion of Science, Grant/Award Number: 18K08324 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4171-2162 |
PMID | 32348592 |
PQID | 2419448657 |
PQPubID | 866394 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2396853411 proquest_journals_2419448657 crossref_primary_10_1002_gcc_22855 pubmed_primary_32348592 wiley_primary_10_1002_gcc_22855_GCC22855 |
PublicationCentury | 2000 |
PublicationDate | September 2020 |
PublicationDateYYYYMMDD | 2020-09-01 |
PublicationDate_xml | – month: 09 year: 2020 text: September 2020 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
PublicationTitle | Genes chromosomes & cancer |
PublicationTitleAlternate | Genes Chromosomes Cancer |
PublicationYear | 2020 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2015; 34 2010; 38 2004; 4 2019; 104 2000; 95 2014; 24 2003; 18 1997; 181 2000; 156 2003; 94 2013; 8 2011; 331 2014; 21 2012; 209 2001; 276 2002; 161 2017; 77 1997; 57 2015; 21 1996; 271 2014; 14 2020; 111 2001; 15 2002; 93 2009; 4 2003; 102 2012; 22 2020; 119 2009; 37 2003; 120 1996; 88 2016; 22 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 Ott G (e_1_2_8_27_1) 1997; 57 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – volume: 21 start-page: 309 issue: 4 year: 2014 end-page: 319 article-title: The origin and targeting of mucosa‐associated lymphoid tissue lymphomas publication-title: Curr Opin Hematol – volume: 77 start-page: 7038 issue: 24 year: 2017 end-page: 7048 article-title: MALT1 inhibition is efficacious in both naive and ibrutinib‐resistant chronic lymphocytic leukemia publication-title: Cancer Res – volume: 21 start-page: 922 issue: 8 year: 2015 end-page: 926 article-title: Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma publication-title: Nat Med – volume: 4 start-page: 44 issue: 1 year: 2009 end-page: 57 article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources publication-title: Nat Protoc – volume: 119 start-page: 35 year: 2020 end-page: 45 article-title: EZH2 inhibitors restore epigenetically silenced CD58 expression in B‐cell lymphomas publication-title: Mol Immunol – volume: 111 start-page: 724 issue: 5 year: 2020 end-page: 732 article-title: Histologic transformation of t(11;18)‐positive MALT lymphoma presented with aberrant T‐cell marker expression publication-title: Int J Hematol – volume: 4 start-page: 644 issue: 8 year: 2004 end-page: 653 article-title: MALT lymphoma: from morphology to molecules publication-title: Nat Rev Cancer – volume: 94 start-page: 774 issue: 9 year: 2003 end-page: 781 article-title: Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B‐cell lymphoma publication-title: Cancer Sci – volume: 93 start-page: 677 issue: 6 year: 2002 end-page: 684 article-title: Clinicopathologic comparison between the API2‐MALT1 chimeric transcript‐positive and ‐negative gastric low‐grade B‐cell lymphoma of mucosa‐associated lymphoid tissue type publication-title: Jpn J Cancer Res – volume: 34 start-page: 2406 issue: 18 year: 2015 end-page: 2409 article-title: A common functional consequence of tumor‐derived mutations within c‐MYC publication-title: Oncogene – volume: 22 start-page: 3593 issue: 14 year: 2016 end-page: 3605 article-title: Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B‐cell lymphoma publication-title: Clin Cancer Res – volume: 38 issue: 16 year: 2010 article-title: ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data publication-title: Nucleic Acids Res – volume: 57 start-page: 3944 issue: 18 year: 1997 end-page: 3948 article-title: The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low‐grade but not high‐grade malignant non‐Hodgkin's lymphomas of the mucosa‐associated lymphoid tissue (MALT‐) type publication-title: Cancer Res – volume: 156 start-page: 1433 issue: 4 year: 2000 end-page: 1439 article-title: The product of the t(11;18), an API2‐MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation publication-title: Am J Pathol – volume: 14 start-page: 502 issue: 7 year: 2014 end-page: 509 article-title: New PARP targets for cancer therapy publication-title: Nat Rev Cancer – volume: 120 start-page: 97 issue: 1 year: 2003 end-page: 100 article-title: High frequency of t(11;18) in gastric mucosa‐associated lymphoid tissue lymphomas in Taiwan, including one patient with high‐grade transformation publication-title: Br J Haematol – volume: 18 start-page: 301 issue: 2 year: 2003 end-page: 312 article-title: Regulation of marginal zone B cell development by MINT, a suppressor of notch/RBP‐J signaling pathway publication-title: Immunity – volume: 271 start-page: 5513 issue: 10 year: 1996 end-page: 5518 article-title: Functional analysis of Burkitt's lymphoma mutant c‐Myc proteins publication-title: J Biol Chem – volume: 102 start-page: 1012 issue: 3 year: 2003 end-page: 1018 article-title: Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma publication-title: Blood – volume: 331 start-page: 468 issue: 6016 year: 2011 end-page: 472 article-title: Cleavage of NIK by the API2‐MALT1 fusion oncoprotein leads to noncanonical NF‐kappaB activation publication-title: Science – volume: 15 start-page: 1140 issue: 9 year: 2001 end-page: 1151 article-title: Sharp, an inducible cofactor that integrates nuclear receptor repression and activation publication-title: Genes Dev – volume: 181 start-page: 381 issue: 4 year: 1997 end-page: 386 article-title: c‐myc gene abnormalities in mucosa‐associated lymphoid tissue (MALT) lymphomas publication-title: J Pathol – volume: 8 issue: 12 year: 2013 article-title: Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma publication-title: PLoS One – volume: 88 start-page: 985 issue: 3 year: 1996 end-page: 994 article-title: Application of long‐distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B‐cell neoplasms publication-title: Blood – volume: 156 start-page: 1183 issue: 4 year: 2000 end-page: 1188 article-title: Incidence and subtype specificity of API2‐MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas publication-title: Am J Pathol – volume: 95 start-page: 802 issue: 3 year: 2000 end-page: 806 article-title: Mucosa‐associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed publication-title: Blood – volume: 209 start-page: 1537 issue: 9 year: 2012 end-page: 1551 article-title: The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development publication-title: J Exp Med – volume: 22 start-page: 812 issue: 6 year: 2012 end-page: 824 article-title: MALT1 small molecule inhibitors specifically suppress ABC‐DLBCL in vitro and in vivo publication-title: Cancer Cell – volume: 161 start-page: 63 issue: 1 year: 2002 end-page: 71 article-title: Mucosa‐associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa‐associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways publication-title: Am J Pathol – volume: 156 start-page: 807 issue: 3 year: 2000 end-page: 812 article-title: API2‐MALT1 chimeric transcripts involved in mucosa‐associated lymphoid tissue type lymphoma predict heterogeneous products publication-title: Am J Pathol – volume: 104 start-page: e558 issue: 12 year: 2019 end-page: e561 article-title: Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses publication-title: Haematologica – volume: 24 start-page: 33 year: 2014 end-page: 42 article-title: Chronic inflammation and extra‐nodal marginal‐zone lymphomas of MALT‐type publication-title: Semin Cancer Biol – volume: 276 start-page: 19012 issue: 22 year: 2001 end-page: 19019 article-title: Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF‐kappa B signaling pathway publication-title: J Biol Chem – volume: 37 start-page: 1 issue: 1 year: 2009 end-page: 13 article-title: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists publication-title: Nucleic Acids Res – ident: e_1_2_8_10_1 doi: 10.1111/j.1349-7006.2002.tb01306.x – ident: e_1_2_8_20_1 doi: 10.3324/haematol.2018.214957 – ident: e_1_2_8_12_1 doi: 10.1111/j.1349-7006.2003.tb01518.x – ident: e_1_2_8_24_1 doi: 10.1038/nrc3748 – ident: e_1_2_8_34_1 doi: 10.1158/0008-5472.CAN-17-2485 – ident: e_1_2_8_22_1 doi: 10.1158/1078-0432.CCR-15-2296 – ident: e_1_2_8_7_1 doi: 10.1016/S0002-9440(10)64157-0 – ident: e_1_2_8_30_1 doi: 10.1016/S0002-9440(10)64988-7 – ident: e_1_2_8_4_1 doi: 10.1097/MOH.0000000000000051 – ident: e_1_2_8_13_1 doi: 10.1016/j.molimm.2020.01.006 – ident: e_1_2_8_3_1 doi: 10.1016/j.semcancer.2013.11.005 – ident: e_1_2_8_11_1 doi: 10.1182/blood.V88.3.985.bloodjournal883985 – ident: e_1_2_8_6_1 doi: 10.1046/j.1365-2141.2003.04035.x – ident: e_1_2_8_35_1 doi: 10.1126/science.1198946 – ident: e_1_2_8_21_1 doi: 10.1038/onc.2014.186 – ident: e_1_2_8_25_1 doi: 10.1182/blood.V95.3.802.003k19_802_806 – ident: e_1_2_8_16_1 doi: 10.1016/S1074-7613(03)00029-3 – ident: e_1_2_8_33_1 doi: 10.1038/nm.3884 – volume: 57 start-page: 3944 issue: 18 year: 1997 ident: e_1_2_8_27_1 article-title: The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low‐grade but not high‐grade malignant non‐Hodgkin's lymphomas of the mucosa‐associated lymphoid tissue (MALT‐) type publication-title: Cancer Res contributor: fullname: Ott G – ident: e_1_2_8_28_1 doi: 10.1016/S0002-9440(10)65012-2 – ident: e_1_2_8_8_1 doi: 10.1007/s12185-019-02810-y – ident: e_1_2_8_14_1 doi: 10.1038/nprot.2008.211 – ident: e_1_2_8_17_1 doi: 10.1101/gad.871201 – ident: e_1_2_8_31_1 doi: 10.1182/blood-2002-11-3502 – ident: e_1_2_8_18_1 doi: 10.1084/jem.20120904 – ident: e_1_2_8_23_1 doi: 10.1074/jbc.271.10.5513 – ident: e_1_2_8_29_1 doi: 10.1016/S0002-9440(10)64948-6 – ident: e_1_2_8_32_1 doi: 10.1016/j.ccr.2012.11.003 – ident: e_1_2_8_26_1 doi: 10.1002/(SICI)1096-9896(199704)181:4<381::AID-PATH787>3.0.CO;2-I – ident: e_1_2_8_19_1 doi: 10.1371/journal.pone.0083244 – ident: e_1_2_8_2_1 doi: 10.1038/nrc1409 – ident: e_1_2_8_5_1 doi: 10.1074/jbc.M009984200 – ident: e_1_2_8_9_1 doi: 10.1093/nar/gkq603 – ident: e_1_2_8_15_1 doi: 10.1093/nar/gkn923 |
SSID | ssj0006395 |
Score | 2.3707712 |
Snippet | MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been... MALT lymphomas with API2(BIRC3)-MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been... MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 517 |
SubjectTerms | API2‐MALT1 Apoptosis cell line Chromosome translocations Endoplasmic reticulum Genetic transformation Heavy chains Immunoglobulins Intestine Lymphoma MALT lymphoma MALT1 inhibitor microarray analysis Mucosal-associated lymphoid tissue Myc protein Polymerase chain reaction Tumor cell lines |
Title | Establishment and characterization of a MALT lymphoma cell line carrying an API2‐MALT1 translocation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fgcc.22855 https://www.ncbi.nlm.nih.gov/pubmed/32348592 https://www.proquest.com/docview/2419448657 https://search.proquest.com/docview/2396853411 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50QfHiY31VV4niwUt1myZ94GlZd1VwZcE9eCtpknrRVvZx2Js_wd_oL3GS7lYWEQShhULTJmQymW-mnW8AzryMK6klc_2UCnRQFHcFDtgNpYeHQeyBLWL7GD48RdcdQ5NzNc-FKfkhqoCb0Qy7XxsFF-no8ps09FnKC0ojbhLM0Uuw6Rt-v9qF0fLykomAu7hmwzmrUJNeVk8u2qIfAHMRr1qD093411A3YX2GM0mrXBhbsKTzOqyUlSendVjtzb6pb0PWQYBoY1EmUEhEroisWJzLJE1SZESQXut-QF6mKP7iVRAT8SdmaESK4dAkS-GjpNW_o5_vH6apR8bGDhpjad6xA4NuZ9C-dWfVF1zJTAFHqakSPM4iqlKuYqHDVAaIxbnELSnOOBeKsRA9INFkOkibLKU8VamQeDZV5u9CLS9yvQ-Eci214ixE6MU8L44CpcMIkSHXgYwj5sDpXAzJW8mxkZRsyjTBqUvs1DnQmAsomanZKEH4EaN_GfDQgZPqNiqImQOR62KCbfw4QEyCHTuwVwq26sWnPot4TB04t_L7vfvkpt22Fwd_b3oIa9R45_aPtAbUxsOJPoLlkZoc27X6BSBT6hc |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB6xVC1caLstkEJbt-qhl5SN48mPxGW1LAV1FyF1D71Fju1wgSxa2AM3HoFn5Ek64-ymQggJqVIiRYoTW54ZzzeTzGeAb1GF1jijwriUmgIUi6GmAYepiehgxJ74TWx_pyd_soMh0-TsL2thGn6INuHGluHXazZwTkjv_WMNPTPmh5QZYgdeqIQUkQs44tN2HSbfiw0XAYaktemSV6gn99pHH3qjRxDzIWL1Lufw9f8N9g1sLKCm6De68RZWXN2Fl83mkzddeDVefFZ_B9WQMKJPR3GuUOjaCtMSOTd1mmJaCS3G_dFEnN-QBkwvtOCkv-CxCaNnM66XokdF__RY3t_ecdNIXLMrZH_J73gPk8PhZHAULjZgCI3iPRyNk1ZjXmXSlmhz7dLSJATH0dCqlFeI2iqVUhCke8olZU-VEktbakNnz1bxJqzW09ptg5DojLOoUkJfKoryLLEuzQgcoktMnqkAvi7lUFw2NBtFQ6gsC5q6wk9dALtLCRULS7sqCIHkFGImmAbwpb1NNsJzoGs3nVObOE8IllDHAWw1km17iWWsMsxlAN-9AJ_uvvg5GPiLD89v-hnWjibjUTE6Pvm1A-uSg3X_g9ourF7P5u4jdK7s_JNX3L_yLu4_ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB6VrVhxgbI8mnZbDOLAJbBxPHmI02of7YpdtFL30Fvk2A6XNosW9sCtP4HfyC9h7OwGoQqpUqVEihQ7tjwezzfj-BuA06BArYwSfphzSQ6KRl9Sh_1YBXRZxB65JLY_4uufSX9gaXIu12dhKn6IOuBmNcOt11bBb3Vx8UIaeqPUOecJ4ga8FwTDLXF-GE7rZZhML1ZUBOjTpI3XtEIdflFXfW2M_kKYrwGrszjDnf_q6wfYXgFN1q1mxi68M2ULNqvUkw8taE5Wm-p7UAwIIbpglI0UMllqpmoa5-qUJpsXTLJJdzxjvx5I_vPfktmQP7NdY0ouFva0FFVl3emIP_15tEUDdm8NobWW9hv7MBsOZr3v_ir9gq-EzeCoDNcS0yLhOkedShPnKiIwjorWpLRAlFqImFwg2REmyjsi55jrXCq6O7oID6BRzkvzERhHo4xGERP2EkGQJpE2cULQEE2k0kR4cLIWQ3ZbkWxkFZ0yz2joMjd0HrTXAspWenaXEf5IycGMMPbguH5NGmLHQJZmvqQyYRoRKKGGPTisBFu3EvJQJJhyD86c_N5uPvvW67mHT_9e9Aia0_4wG4-urz7DFreeuvs7rQ2N-8XSfIGNO7386qbtMxlX7OU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Establishment+and+characterization+of+a+MALT+lymphoma+cell+line+carrying+an+API2%E2%80%90MALT1+translocation&rft.jtitle=Genes+chromosomes+%26+cancer&rft.au=Izumi%2C+Kiyotaka&rft.au=Nishikori%2C+Momoko&rft.au=Yuan%2C+Hepei&rft.au=Otsuka%2C+Yasuyuki&rft.date=2020-09-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1045-2257&rft.eissn=1098-2264&rft.volume=59&rft.issue=9&rft.spage=517&rft.epage=524&rft_id=info:doi/10.1002%2Fgcc.22855&rft.externalDBID=10.1002%252Fgcc.22855&rft.externalDocID=GCC22855 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-2257&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-2257&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-2257&client=summon |